Go Pro
NASDAQ:HCAT

Health Catalyst (HCAT) Stock Price, News & Analysis

Health Catalyst logo
$2.28 +0.07 (+3.17%)
Closing price 04:00 PM Eastern
Extended Trading
$2.28 0.00 (-0.22%)
As of 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Health Catalyst Stock (NASDAQ:HCAT)

Advanced

Key Stats

Today's Range
$2.22
$2.28
50-Day Range
$1.30
$2.33
52-Week Range
$0.96
$3.88
Volume
471,649 shs
Average Volume
639,739 shs
Market Capitalization
$168.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.93
Consensus Rating
Hold

Company Overview

Health Catalyst (NASDAQ: HCAT) is a healthcare data and analytics technology company founded in 2008 and headquartered in Salt Lake City, Utah. The company went public in 2019 and has since focused on delivering a unified data platform that helps healthcare organizations aggregate and analyze clinical, financial and operational information.

The core of Health Catalyst’s offering is the Data Operating System (DOS), a modular data management platform that integrates disparate data sources—from electronic health records to claims and patient-generated data—into a single analytics environment. Built on cloud-native architecture, DOS provides analytics applications and tools for care management, performance improvement, population health and financial analysis.

In addition to its platform technology, Health Catalyst provides professional services including implementation support, data engineering, performance improvement consulting and change management. These services are designed to help health systems and hospitals accelerate adoption of data-driven practices, improve clinical quality and reduce costs through evidence-based interventions.

Health Catalyst serves more than 450 healthcare organizations across the United States and has expanded its footprint into select international markets. The company is led by an executive team with deep experience in health IT and population health, and it partners with clients ranging from community hospitals to large integrated health systems to drive measurable improvements in patient outcomes and operational efficiency.

AI Generated. May Contain Errors.

Health Catalyst Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
75th Percentile Overall Score

HCAT MarketRank™: 

Health Catalyst scored higher than 75% of companies evaluated by MarketBeat, and ranked 172nd out of 893 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Health Catalyst has received a consensus rating of Hold. The company's average rating score is 2.23, and is based on no strong buy ratings, 4 buy ratings, 8 hold ratings, and 1 sell rating.

  • Upside Potential

    Health Catalyst has a consensus price target of $2.93, representing about 28.6% upside from its current price of $2.28.

  • Amount of Analyst Coverage

    Health Catalyst has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Health Catalyst's stock forecast and price target.
  • Earnings Growth

    Earnings for Health Catalyst are expected to grow in the coming year, from ($0.25) to ($0.24) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Health Catalyst is -0.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Health Catalyst is -0.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Health Catalyst has a P/B Ratio of 0.66. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Health Catalyst's valuation and earnings.
  • Percentage of Shares Shorted

    6.12% of the float of Health Catalyst has been sold short.
  • Short Interest Ratio / Days to Cover

    Health Catalyst has a short interest ratio ("days to cover") of 3.78, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Health Catalyst has recently decreased by 20.70%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Health Catalyst does not currently pay a dividend.

  • Dividend Growth

    Health Catalyst does not have a long track record of dividend growth.

  • News Sentiment

    Health Catalyst has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.69 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Health Catalyst this week, compared to 3 articles on an average week.
  • Search Interest

    Only 4 people have searched for HCAT on MarketBeat in the last 30 days. This is a decrease of -60% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Health Catalyst insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    19.40% of the stock of Health Catalyst is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    85.00% of the stock of Health Catalyst is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Health Catalyst's insider trading history.
Receive HCAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Health Catalyst and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HCAT Stock News Headlines

Central banks bought 710 tonnes - this fund pays monthly
Gold is hitting new highs, fueled by tariffs and record central bank demand - 710 tonnes per quarter. JPMorgan is now targeting $4,900. One $15 fund is converting gold's momentum into up to $1,152 per month in payouts. No miners, no active trading - just monthly income.tc pixel
3 Reasons to Sell HCAT and 1 Stock to Buy Instead
HCAT Share News Today
See More Headlines

HCAT Stock Analysis - Frequently Asked Questions

Health Catalyst's stock was trading at $2.39 at the beginning of 2026. Since then, HCAT shares have decreased by 4.6% and is now trading at $2.28.

Health Catalyst, Inc. (NASDAQ:HCAT) issued its quarterly earnings results on Monday, May, 11th. The company reported $0.02 EPS for the quarter, topping the consensus estimate of $0.01 by $0.01. The firm had revenue of $70.76 million for the quarter, compared to analysts' expectations of $69.24 million. Health Catalyst had a negative trailing twelve-month return on equity of 3.52% and a negative net margin of 87.69%.
Read the conference call transcript
.

Health Catalyst (HCAT) raised $172 million in an initial public offering on Wednesday, July 24th 2019. The company issued 7,000,000 shares at $24.00-$25.00 per share. Goldman Sachs, J.P. Morgan and William Blair acted as the underwriters for the IPO and Piper Jaffray, Evercore ISI, SVB Leerink and SunTrust Robinson Humphrey were co-managers.

Health Catalyst's top institutional investors include Williams & Novak LLC (0.07%). Insiders that own company stock include Kevin Lee Freeman, Daniel Lesueur, Benjamin Landry, Jason Alger, Linda Llewelyn, Julie Larson-Green and Duncan Gallagher.
View institutional ownership trends
.

Shares of HCAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Health Catalyst investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), The RMR Group (RMR), AUO (AUOTY), Voyager Therapeutics (VYGR) and DiamondRock Hospitality (DRH).

Company Calendar

Last Earnings
5/11/2026
Today
8/04/2026
Next Earnings (Estimated)
8/06/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Technology
Sub-Industry
Healthcare Technology
Current Symbol
NASDAQ:HCAT
CIK
1636422
Fax
N/A
Employees
1,200
Year Founded
2008

Price Target and Rating

High Price Target
$5.00
Low Price Target
$1.75
Potential Upside/Downside
+28.6%
Consensus Rating
Hold
Rating Score (0-4)
2.23
Research Coverage
13 Analysts

Profitability

EPS (Trailing Twelve Months)
($3.72)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$177.97 million
Net Margins
-87.69%
Pretax Margin
-87.39%
Return on Equity
-3.52%
Return on Assets
-1.77%

Debt

Debt-to-Equity Ratio
1.10
Current Ratio
1.69
Quick Ratio
1.69

Sales & Book Value

Annual Sales
$311.14 million
Price / Sales
0.54
Cash Flow
$2.19 per share
Price / Cash Flow
1.04
Book Value
$3.47 per share
Price / Book
0.66

Miscellaneous

Outstanding Shares
73,890,000
Free Float
59,559,000
Market Cap
$168.47 million
Optionable
Optionable
Beta
1.55

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:HCAT) was last updated on 8/4/2026 by MarketBeat.com Staff.
From Our Partners